Purpose: To compare the outcomes of mycophenolate mofetil (MMF) versus methotrexate (MTX) in non-infectious ocular inflammatory disease (NIOID).
Methods: The study was performed as per the PRISMA Guidelines. A search identified all studies comparing MMF versus MTX in NIOID.